Form 4 for BIVI BIOVIE INC.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001520138-24-000099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-03-06 | 2024-03-04 | BIVI | DO CUONG V | Pres, CEO, Dir | P - Purchase | — | +10.0K | 435.9K | +2% | — |
| DI | 2024-03-06 | 2024-03-04 | BIVI | DO CUONG V | Pres, CEO, Dir | P - Purchase | — | +5,000 | 5,000 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-03-04 | P | A | 10,000 | — | 435,854 | I See Footnote | — | — | (F1) The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $1.00 in connection with the issuer's public offering that closed on March 6, 2024. (F2) Securities are held in the name of Do & Rickles Investments LLC. |
| 2 | Derivative | Warrants (right to buy) | 2024-03-04 | P | A | 5,000 | — | 5,000 | I See Footnote | $1.50 · 2024-03-04 to 2029-03-04 | 5,000 Common Stock | (F1) The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $1.00 in connection with the issuer's public offering that closed on March 6, 2024. (F2) Securities are held in the name of Do & Rickles Investments LLC. |